趋化因子配体2(CXCL2)检测试剂盒(酶联免疫吸附试验法)
ELISA Kit for Chemokine (C-X-C Motif) Ligand 2 (CXCL2)
GROb; SCYB2; MIP2; GRO2; MIP2a; MGSAb; CINC2a; HSF; Macrophage inflammatory protein 2-alpha; Hematopoietic synergistic factor; Growth Regulated Oncogene Beta
- 编号SEB603Mu
- 物种Mus musculus (Mouse,小鼠) 相同的名称,不同的物种。
- 实验方法双抗夹心
- 反应时长3h
- 检测范围15.6-1,000pg/mL
- 灵敏度最小可检测剂量小于等于5.5pg/mL.
- 样本类型Serum, plasma, tissue homogenates, cell lysates, cell culture supernates and other biological fluids
- 下载 英文说明书 中文说明书
- 规格 48T96T 96T*5 96T*10 96T*100
- 价格 ¥ 1672 ¥ 2388 ¥ 10746 ¥ 20298 ¥ 167160
- 欲了解实际交易价格和更多情况,请与当地经销商联系!
特异性
本试剂盒用于检测趋化因子配体2(CXCL2),经检测与其它相似物质无明显交叉反应。
由于受到技术及样本来源的限制,不可能完成对所有相关或相似物质交叉反应检测,因此本试剂盒有可能与未经检测的其它物质有交叉反应。
回收率
分别于定值血清及血浆样本中加入一定量的趋化因子配体2(CXCL2)(加标样品),重复测定并计算其均值,回收率为测定值与理论值的比率。
样本 | 回收率范围(%) | 平均回收率(%) |
serum(n=5) | 91-105 | 101 |
EDTA plasma(n=5) | 89-96 | 93 |
heparin plasma(n=5) | 87-103 | 97 |
精密度
精密度用样品测定值的变异系数CV表示。CV(%) = SD/mean×100
批内差:取同批次试剂盒对低、中、高值定值样本进行定量检测,每份样本连续测定20 次,分别计算不同浓度样本的平均值及SD值。
批间差:选取3个不同批次的试剂盒分别对低、中、高值定值样本进行定量测定,每个样本使用同一试剂盒重复测定8次,分别计算不同浓度样本的平均值及SD值。
批内差: CV<10%
批间差: CV<12%
线性
在定值血清及血浆样本内加入适量的趋化因子配体2(CXCL2),并倍比稀释成1:2,1:4,1:8,1:16的待测样本,线性范围即为稀释后样本中趋化因子配体2(CXCL2)含量的测定值与理论值的比率。
样本 | 1:2 | 1:4 | 1:8 | 1:16 |
serum(n=5) | 99-105% | 78-92% | 83-96% | 95-102% |
EDTA plasma(n=5) | 88-104% | 96-105% | 95-103% | 78-92% |
heparin plasma(n=5) | 95-103% | 97-104% | 94-102% | 78-90% |
稳定性
经测定,试剂盒在有效期内按推荐温度保存,其活性降低率小于5%。
为减小外部因素对试剂盒破坏前后检测值的影响,实验室的环境条件需尽量保持一致,尤其是实验室内温度、湿度及温育条件。其次由同一实验员来进行操作可减少人为误差。
实验流程
1. 实验前标准品、试剂及样本的准备;
2. 加样(标准品及样本)100µL,37°C孵育1小时;
3. 吸弃,加检测溶液A100µL,37°C孵育1小时;
4. 洗板3次;
5. 加检测溶液B100µL,37°C孵育30分钟;
6. 洗板5次;
7. 加TMB底物90µL,37°C孵育10-20分钟;
8. 加终止液50µL,立即450nm读数。
实验原理
将趋化因子配体2(CXCL2)抗体包被于96孔微孔板中,制成固相载体,向微孔中分别加入标准品或标本,其中的趋化因子配体2(CXCL2)与连接于固相载体上的抗体结合,然后加入生物素化的趋化因子配体2(CXCL2)抗体,将未结合的生物素化抗体洗净后,加入HRP标记的亲和素,再次彻底洗涤后加入TMB底物显色。TMB在过氧化物酶的催化下转化成蓝色,并在酸的作用下转化成最终的黄色。颜色的深浅和样品中的趋化因子配体2(CXCL2)呈正相关。用酶标仪在450nm波长下测定吸光度(O.D.值),计算样品浓度。
增值服务
相关产品
编号 | 适用物种:Mus musculus (Mouse,小鼠) | 应用(仅供研究使用,不用于临床诊断!) |
RPB603Mu01 | 趋化因子配体2(CXCL2)重组蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
EPB603Mu51 | 趋化因子配体2(CXCL2)真核蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
RPB603Mu02 | 趋化因子配体2(CXCL2)重组蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
PAB603Mu07 | 趋化因子配体2(CXCL2)多克隆抗体 | WB; IHC; ICC; IP. |
PAB603Mu02 | 趋化因子配体2(CXCL2)多克隆抗体 | WB; IHC; ICC; IP. |
PAB603Mu01 | 趋化因子配体2(CXCL2)多克隆抗体 | WB; IHC; ICC; IP. |
PAB603Mu51 | 趋化因子配体2(CXCL2)多克隆抗体 | WB; IHC; ICC; IP. |
SEB603Mu | 趋化因子配体2(CXCL2)检测试剂盒(酶联免疫吸附试验法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
MEB603Mu | 趋化因子配体2(CXCL2)检测试剂盒(酶联免疫吸附试验法,小样本) | Enzyme-linked immunosorbent assay for Antigen Detection. |
LMB603Mu | 趋化因子配体2(CXCL2)等多因子检测试剂盒(流式荧光发光法) | FLIA Kit for Antigen Detection. |
参考文献
杂志 | 参考文献 |
FEBS Journal | Tumour necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced chemokine release in both TRAIL-resistant and TRAIL-sensitive cells via nuclear factor kappa B [PubMed: 19120450] |
PLoS One. | HIF-1α Is Essential for Effective PMN Bacterial Killing, Antimicrobial Peptide Production and Apoptosis in Pseudomonas aeruginosa Keratitis [Plos: Source] |
Physiol Genomics. | Identification of human exercise-induced myokines using secretome analysis [Pubmed:24520153] |
Diabetes | Protein Inhibitor of Activated STAT 1 (PIAS1) Protects Against Obesity-Induced Insulin Resistance by Inhibiting Inflammation Cascade in Adipose Tissue [PubMed: 26324179] |
Respiration | Bubble CPAP support after discontinuation of mechanical ventilation protects rat lungs with ventilator-induced lung injury [Pubmed:26800273] |
Scientific Reports | The Transcriptional Foundations of Sp110-mediated Macrophage (RAW264. 7) Resistance to Mycobacterium tuberculosis H37Ra [Pubmed:26912204] |
Cellular Physiology and Biochemistry | Dexmedetomidine Alleviates HyperoxiaInduced Acute Lung Injury via Inhibiting NLRP3 Inflammasome Activation [pubmed:28873369] |
Medicine (Baltimore) | Rapid detection of urinary soluble intercellular adhesion molecule-1 for determination of lupus nephritis activity [Pubmed:29953010] |
Hepatology | Integrated Omics Reveals Tollip as an Aggravator and Therapeutic Target for Hepatic Ischemia‐Reperfusion Injury in Mice [Pubmed: 31077413] |
Molecular Medicine Reports | IL‑17A promotes CXCR2‑dependent angiogenesis in a mouse model of liver cancer [Pubmed: 31173199] |
Anticancer Research | The Clinicopathological Significance of the CXCR2 Ligands, CXCL1, CXCL2, CXCL3, CXCL5, CXCL6, CXCL7, and CXCL8 in Gastric Cancer [Pubmed: 31810929] |
Lab Invest | Extracellular cold-inducible RNA-binding protein regulates neutrophil extracellular trap formation and tissue damage in acute pancreatitis [Pubmed: 32709888] |
SCIENCE OF THE TOTAL ENVIRONMENT | Assessment of acute toxicological effects of molybdenum (IV) disulfide nano-and microparticles after single intratracheal administration in rats [Pubmed: 32629262] |
Autophagy | Vitamin D3 and carbamazepine protect against Clostridioides difficile infection in mice by restoring macrophage lysosome acidification [Pubmed:34989311] |